| |
Latest 10 SEC filings (by transaction date) for REGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -13 | $965.35 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -16 | $964.45 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -20 | $963.60 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -9 | $962.42 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -14 | $961.59 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -15 | $960.53 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -9 | $959.47 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -2 | $958.86 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -2 | $957.78 |
Apr 3/24 | Apr 1/24 | McCourt Marion | Direct Ownership | Common Stock | S - Open market or private sale | -250 | $964.73 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for REGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -13 | $965.35 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -16 | $964.45 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -20 | $963.60 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -9 | $962.42 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -14 | $961.59 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -15 | $960.53 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -9 | $959.47 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -2 | $958.86 |
Apr 3/24 | Apr 1/24 | Ryan Arthur F | Direct Ownership | Common Stock | S - Open market or private sale | -2 | $957.78 |
Apr 3/24 | Apr 1/24 | McCourt Marion | Direct Ownership | Common Stock | S - Open market or private sale | -250 | $964.73 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Madrigal Pharmaceuticals (OQ:MDGL) |
Vertex Pharmaceuticals (OQ:VRTX) |